Integra Therapeutics, first company to move into Advanced Therapies Platform at SJD Barcelona Children's Hospital

by Integra Therapeutics

Integra Therapeutics has developed the FiCAT gene-writing platform to develop cell therapies for autoimmune and oncology diseases and gene therapies for rare diseases. The company recently announced a...

Read more

IBEC spin-off Nanobots Therapeutics receives IMPACTO grant from the Spanish Association Against Cancer

by IBEC - Institut de Bioenginyeria de Catalunya

IBEC spin-off Nanobots Therapeutics has been selected in the AECC’s 2024 call for IMPACTO grants. This is an initiative of the Spanish Association Against Cancer (AECC) aimed at technology-based mic...

Read more

AECC funds new paths to thwart cancer’s deadliest moves

by Centre for Genomic Regulation

Two researchers at the Centre for Genomic Regulation (CRG) in Barcelona are tackling an urgent question: how can we stop cancer before it spreads? Thanks to new grants from the Spanish Association Aga...

Read more

Clinical trial on personalized physical exercise for elderly cancer patients shows promising preliminary results

by Vall d’Hebron

It is part of the PROFIT Project (Personalizing the Approach to Frail Oncology Patients through Assessment and Individualized Intervention), an innovative initiative focused on providing comprehensive...

Read more

New technique reveals how the same mutations give rise to very different types of leukaemia

by IRB Barcelona - Instituto de Investigación Biomédica

A study from IRB Barcelona, funded by Fundación CRIS contra el cáncer, demonstrates that the “previous state” of blood stem cells plays a decisive role in the subtype of leukaemia that develops....

Read more

Adcendo ApS Announces U.S. FDA Clearance of IND Application for Phase I Tiffany-01 Trial of ADCE-T02

by Ysios Capital

ADCE-T02 is a potential first-in-class Topoisomerase I inhibitor-based antibody-drug conjugate (ADC) targeting tissue factor, a validated ADC target overexpressed in multiple solid tumors

Read more

Nuevo modelo matemático para mejorar la administración de fármacos tras la cirugía de cáncer de mama

by Instituto de Investigación Biomédica de Salamanca - IBSAL

El estudio, publicado en la European Journal of Pharmaceutical Sciences, propone el uso de un hidrogel biodegradable que se coloca en la cavidad dejada por el tumor tras la cirugía. Este material lib...

Read more

Novel nanomotors improve bladder cancer immunotherapy

by IBEC - Institut de Bioenginyeria de Catalunya

A study describes the development of urea-powered nanomotors that improve immunotherapy for bladder cancer. The nanomotors activate the immune system more efficiently and exceed the efficacy of curren...

Read more

Antibody samples: Discover our AbyPanels and 5 of their advantages

by Abyntek
  • 1 year ago

At ABYLABEL, they are commited to excellence and social responsability. This is why they are proud to present their AbyPanels, a tool that saves time and modey in the development of antibodies for res...

Read more

ORYZON reports financial results and corporate update for Q4 2024

by Oryzon Genomics

​Oryzon Genomics, S.A, a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, today reported financial results for the fou...

Read more

El Hospital público 12 de Octubre de la Comunidad de Madrid lidera un ensayo en adolescentes con cáncer basado en ejercicio físico y buenos hábitos

by Hospital Universitario 12 de Octubre

El Hospital público Universitario 12 de Octubre de la Comunidad de Madrid lidera un ensayo clínico en adolescentes con cáncer para estudiar los resultados de una intervención basada en ejercicio f...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Telum Therapeutics Secures €18 Million...

by Telum Therapeutics

Telum Therapeutics, a biotechnology company leveraging proprietary met...

Photos Stream